Isofra - instructions for use, reviews, analogues and forms of release (nasal spray 1.25% drops in the nose) of a drug for the treatment of sinusitis in adults, children and in pregnancy based on the antibiotic of Framicetin
In this article, you can read the instructions for using the drug Isofra. There are reviews of visitors to the site - consumers of this medication, as well as opinions of doctors of specialists on the use of Isofra in their practice. A big request is to actively add their feedback on the drug: the medicine helped or did not help get rid of the disease, which were observed complications and side effects, possibly not declared by the manufacturer in the annotation. Analogues of Isophra in the presence of existing structural analogues. Use for the treatment of sinusitis and rhinitis in adults, children, as well as in pregnancy and breast-feeding a drug based on the antibiotic of Framicetin.
Isofra - antibiotic from the group of aminoglycosides for topical application in otorhinolaryngology. It is bactericidal. It is active against gram-positive and gram-negative bacteria that cause the development of infectious processes in the upper respiratory tract.
Composition
Framicetin sulfate + excipients.
Pharmacokinetics
Studies of the pharmacokinetics of the preparation of Isophra have not been carried out due to low systemic absorption.
Indications
As part of combination therapy for infectious and inflammatory diseases of the upper respiratory tract, including:
- rhinitis;
- rhinopharyngitis;
- sinusitis (in the absence of damage to the septum);
- prevention and treatment of inflammatory processes after surgical interventions.
Forms of release
Spray nasal 1.25% (sometimes mistakenly called drops in the nose).
Instructions for use and dosing regimen
Adults appoint 1 injection in each nostril 4-6 times a day.
Children are prescribed 1 injection in each nostril 3 times a day.
The average duration of therapy is 7 days.
When using the bottle should be kept in a vertical position.
Side effect
- allergic reactions (skin manifestations).
Contraindications
- increased sensitivity to framicetin and other antibiotics from the aminoglycoside group.
Application in pregnancy and lactation
Adequate and strictly controlled clinical studies of the safety of the use of Isofra during pregnancy and lactation (breastfeeding) were not carried out.
special instructions
If the therapeutic effect is absent or weakly expressed within 7 days of treatment, the drug must be discontinued.
Drug Interactions
Clinically significant interactions of the preparation with other medicines have not been identified.
Analogues of Isophra drug
There are no structural analogs to the active substance of Isophra.
Analogues for the pharmacological group (Aminoglycosides):
- Amycocal;
- Amicacin;
- Amikin;
- Amycositis;
- Bramitob;
- Brulamycin;
- Garamycin;
- Gentamicin;
- Dilaterol;
- Kanamycin;
- Kirin;
- Lycasin;
- Nebzin;
- Neomycin;
- Netromycin;
- Nettavisk;
- Selemycin;
- Streptomycin;
- Toby;
- Tobrex;
- Tobrup;
- Trobitsin;
- Farcicline;
- Hemacin.
Similar medicines:
Other medicines:
- Agents of influence of pharmaceutical companies and their punctures
- Enap - instructions for use, reviews, analogs and formulations (tablets 2.5 mg, 5 mg, 10 mg and 20 mg HL, H and in R injections) drugs for the treatment of hypertension and pressure reduction in adults, children and in pregnancy
- Kodelak - instructions for use, reviews, analogs and form of release (syrup Fito, Broncho tablets, elixir with thyme) of a drug for cough treatment in adults, children and pregnancy